AbdelHai Hammo

Professor

Last publication 2024 Last refreshed 2026-03-16

faculty

COM | Peds Gastroenterology

1 h-index 2 pubs 8 cited

Biography and Research Information

OverviewAI-generated summary

AbdelHai Hammo's research focuses on the clinical effectiveness and safety of ustekinumab in pediatric and adolescent patients diagnosed with refractory inflammatory bowel disease. His work includes retrospective cohort studies examining treatment outcomes in these young populations. Hammo has published on the efficacy and safety of ustekinumab in youth with inflammatory bowel disease, with a particular emphasis on outcomes in specific geographic regions. His scholarship metrics include an h-index of 1 with 2 total publications and 8 total citations.

Metrics

  • h-index: 1
  • Publications: 2
  • Citations: 8

Selected Publications

  • Clinical effectiveness and safety of ustekinumab in youth with refractory inflammatory bowel disease: A retrospective cohort study (2024)
    8 citations DOI OpenAlex
  • A222 CLINICAL EFFECTIVENESS AND SAFETY OF USTEKINUMAB IN YOUTH WITH REFRACTORY INFLAMMATORY BOWEL DISEASE IN SAUDI ARABIA: A RETROSPECTIVE COHORT STUDY (2024)

View all publications on OpenAlex →

Collaboration Network

5 Collaborators 2 Institutions 2 Countries

Top Collaborators

Similar Researchers

Based on overlapping research topics